Genome-Wide Gene Expression Analyses of <i>BRCA1</i>- and <i>BRCA2</i>-Associated Breast and Ovarian Tumours
Germline pathogenic variants in <i>BRCA1</i> and <i>BRCA2</i> increase cumulative lifetime risk up to 75% for breast cancer and 76% for ovarian cancer. Genetic testing for <i>BRCA1</i> and <i>BRCA2</i> pathogenic variants has become an important part o...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/3015 |